Chen P, Wang W, Wong S, Li J, Wu Q, Zhang S, et al. RUNDC3A regulates SNAP25-mediated chemotherapy resistance by binding AKT in gastric neuroendocrine carcinoma (GNEC). Cell Death Discov. 2022;8:296 pubmed publisher

Palma M, Leroy C, Salomé Desnoulez S, Werkmeister E, Kong R, Mongy M, et al. A role for AKT1 in nonsense-mediated mRNA decay. Nucleic Acids Res. 2021;49:11022-11037 pubmed publisher

Tooley A, Kazyken D, Bodur C, Gonzalez I, Fingar D. The innate immune kinase TBK1 directly increases mTORC2 activity and downstream signaling to Akt. J Biol Chem. 2021;297:100942 pubmed publisher

Wie J, Liu Z, Song H, Tropea T, Yang L, Wang H, et al. A growth-factor-activated lysosomal K+ channel regulates Parkinson's pathology. Nature. 2021;: pubmed publisher

Zhu L, Yang H, Chao Y, Gu Y, Zhang J, Wang F, et al. Akt phosphorylation regulated by IKKε in response to low shear stress leads to endothelial inflammation via activating IRF3. Cell Signal. 2021;80:109900 pubmed publisher

Yue X, Wu F, Li Y, Liu J, Boateng M, Mandava K, et al. Gain of function mutant p53 protein activates AKT through the Rac1 signaling to promote tumorigenesis. Cell Cycle. 2020;19:1338-1351 pubmed publisher

Chu N, Salguero A, Liu A, Chen Z, Dempsey D, Ficarro S, et al. Akt Kinase Activation Mechanisms Revealed Using Protein Semisynthesis. Cell. 2018;174:897-907.e14 pubmed publisher

Valentino E, Bellazzo A, Di Minin G, Sicari D, Apollonio M, Scognamiglio G, et al. Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP. Proc Natl Acad Sci U S A. 2017;114:7623-7628 pubmed publisher

Fei L, Ma Y, Zhang M, Liu X, Luo Y, Wang C, et al. RACK1 promotes lung cancer cell growth via an MCM7/RACK1/ Akt signaling complex. Oncotarget. 2017;8:40501-40513 pubmed publisher

Tobisawa T, Yano T, Tanno M, Miki T, Kuno A, Kimura Y, et al. Insufficient activation of Akt upon reperfusion because of its novel modification by reduced PP2A-B55α contributes to enlargement of infarct size by chronic kidney disease. Basic Res Cardiol. 2017;112:31 pubmed publisher

Pinton G, Zonca S, Manente A, Cavaletto M, Borroni E, Daga A, et al. SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells. Oncotarget. 2016;7:14366-79 pubmed publisher

De Marco C, Malanga D, Rinaldo N, De Vita F, Scrima M, Lovisa S, et al. Mutant AKT1-E17K is oncogenic in lung epithelial cells. Oncotarget. 2015;6:39634-50 pubmed publisher

Lopez S, Hodgson M, Packianathan C, Bingöl Özakpınar Ö, Uras F, Rosen B, et al. Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities. Biochem Biophys Res Commun. 2013;440:277-82 pubmed publisher

Wu X, Bhayani M, Dodge C, Nicoloso M, Chen Y, Yan X, et al. Coordinated targeting of the EGFR signaling axis by microRNA-27a*. Oncotarget. 2013;4:1388-98 pubmed

Wang S, Huang X, Sun D, Xin X, Pan Q, Peng S, et al. Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling. PLoS ONE. 2012;7:e37427 pubmed publisher

Martin V, Wang W, Lipchik A, Parker L, He Y, Zhang S, et al. Akt2 inhibits the activation of NFAT in lymphocytes by modulating calcium release from intracellular stores. Cell Signal. 2012;24:1064-73 pubmed publisher

Hsieh A, Bo R, Manola J, Vazquez F, Bare O, Khvorova A, et al. A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens. Nucleic Acids Res. 2004;32:893-901 pubmed